Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q2 2025 · 10-Q
Revenue$3.22M$3.22M+12.2% vs Q2 2024 Net Income$246.02K$246.02KN/M vs Q2 2024 EPS Diluted$0.02$0.02N/M vs Q2 2024 Operating Income$255,904N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$300,941N/M Margins · derivedOperating margin7.9%+10.4 pt vs Q2 2024
Net margin7.6%+10.3 pt vs Q2 2024
ended Dec 31, 2024 · filed Feb 14, 2025 · 45 d after period end